End-to-end compliance with ICH S7 Guidelines
These studies are designed to identify the undesirable pharmacodynamic properties of a compound relevant to human safety in three areas — Cardiovascular, Respiratory and the Central Nervous System.
We partner with you on the following studies:
- Cardiovascular system
- Chronically instrumented conscious canine, NHP radiotelemetry to telemetry, and mini pig models using radiotelemetry
- Respiratory system
- Rodent whole body and head-out plethysmography
- Arterial blood gas in nonhuman primates
- Central Nervous System
- Modified Irwin test in rodents and nonhuman primates
- Automated behavioral assessment in nonhuman primates
- Combination cardiovascular/respiratory
- Jacketed assessments with respiratory inductive plethysmography
